BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32444799)

  • 1. The FBW7-MCL-1 axis is key in M1 and M2 macrophage-related colon cancer cell progression: validating the immunotherapeutic value of targeting PI3Kγ.
    Lee YS; Song SJ; Hong HK; Oh BY; Lee WY; Cho YB
    Exp Mol Med; 2020 May; 52(5):815-831. PubMed ID: 32444799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ.
    Yuan M; Zou X; Liu S; Xu X; Wang H; Zhu M; Xie X; Wang H; Wu J; Sun Q
    Biomed Pharmacother; 2020 Sep; 129():110440. PubMed ID: 32768942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
    Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
    Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 5. PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.
    Cheng Y; Zhu Y; Xu J; Yang M; Chen P; Xu W; Zhao J; Geng L; Gong S
    Mol Cancer; 2018 Jan; 17(1):13. PubMed ID: 29368606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells.
    Zhang W; Chen L; Ma K; Zhao Y; Liu X; Wang Y; Liu M; Liang S; Zhu H; Xu N
    Oncotarget; 2016 Nov; 7(46):75366-75378. PubMed ID: 27683110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F1 fraction isolated from Mesobuthus eupeus scorpion venom induces macrophage polarization toward M1 phenotype and exerts anti-tumoral effects on the CT26 tumor cell line.
    Sadeghi M; Amari A; Asadirad A; Nemati M; Khodadadi A
    Int Immunopharmacol; 2024 May; 132():111960. PubMed ID: 38554440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon cancer cells secreted CXCL11 via RBP-Jκ to facilitated tumour-associated macrophage-induced cancer metastasis.
    Liu M; Fu X; Jiang L; Ma J; Zheng X; Wang S; Guo H; Tian T; Nan K; Wang W
    J Cell Mol Med; 2021 Nov; 25(22):10575-10590. PubMed ID: 34655278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Preventive Effect of the Phenotype of Tumour-Associated Macrophages, Regulated by CD39, on Colon Cancer in Mice.
    Park HJ; Seo EH; Piao L; Park ST; Lee MK; Koh SE; Lee SH; Kim SH
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
    Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
    Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression.
    Joshi S; Liu KX; Zulcic M; Singh AR; Skola D; Glass CK; Sanders PD; Sharabi AB; Pham TV; Tamayo P; Shiang D; Dinh HQ; Hedrick CC; Morales GA; Garlich JR; Durden DL
    Mol Cancer Ther; 2020 Mar; 19(3):755-764. PubMed ID: 31974273
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Tong J; Tan S; Nikolovska-Coleska Z; Yu J; Zou F; Zhang L
    Mol Cancer Ther; 2017 Sep; 16(9):1979-1988. PubMed ID: 28619760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
    Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
    Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-1,6 glucan converts tumor-associated macrophages into an M1-like phenotype.
    Cheng H; Sun L; Shen D; Ren A; Ma F; Tai G; Fan L; Zhou Y
    Carbohydr Polym; 2020 Nov; 247():116715. PubMed ID: 32829842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Polarization States in the Tumor Microenvironment.
    Boutilier AJ; Elsawa SF
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response.
    Li J; Kaneda MM; Ma J; Li M; Shepard RM; Patel K; Koga T; Sarver A; Furnari F; Xu B; Dhawan S; Ning J; Zhu H; Wu A; You G; Jiang T; Venteicher AS; Rich JN; Glass CK; Varner JA; Chen CC
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.